Case Study: FNP and Adult Gero Primary Care NPA 52-year-old female patient presents for follow-up 7 days after hospitalization for her first deep vein thrombosis (DVT) in the left leg. She is currently taking rivaroxaban (Xarelto) 15 mg once daily. She had thrombolysis while in hospital and reports a decrease in swelling and tenderness of left leg. She also is positive for Factor V Leiden. The patient is in today and asking why she is taking rivaroxaban and not warfarin (Coumadin) like some of her friends who had a similar problem. She also wants to know how long she should be on rivaroxaban. Past Medical History- Patient also reports that she is asthmatic and hypertensive.Allergies- None KnownMedications- Rivaroxaban 15 mg daily, HCTZ 25 mg daily, Advair 250/50 daily, Ibuprofen 400-600 mg po prnPhysical Exam:Weight: 160 lb Height: 65 in BMI: 26.6 BP: 160/92 Temp: 98 Pulse: 70 Resp: 18Labs:CBC: WBC: 10.2 HGB: 13 HCT: 40 PLT: 326BMP: Glucose: 145 BUN: 28 Creat: 1.5 K: 3.9 CrCl 50 mL/minLFT: AST: 35 ALT: 42 Alk Phos: 35 Please answer the following questions related to the case study. Your answers should be brief and to the point for ALL questions. The word count is outlined within each question. Points will be deducted for going over the word limit for each question. Clinical Guidelines: Use the link below to access the current clinical guidelines.Kearon, C., Akl, E., Ornelas, J., Blaivas, A., Jimenez, D., Bounameax, H.,...Moores, L. (2016). Antithrombotic therapy for VTE disease: CHEST guidelines and expert panel report. Chest, 149, 315-352. Available from: the pathophysiology of a DVT.
(in no more than 150 words)List the tests that should be included in a coagulation panel and briefly describe what the test measures and why each is needed. (in no more than 150 words)